Meganucleases (Cellectis)

N/A

Report date: 2025/01/26 17:17:54

Base Information

Drug NameMeganucleases (Cellectis)
Drug Alias NameMeganucleases (Cellectis)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionEndonucleases modulators
TargetsEndonucleases
Therapy Area/IndicationsHemophilia AMuscular Dystrophy, DuchenneHerpesviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellectis Sa
China Registration ClassN/A

Develop Information

Active CompaniesCellectis Sa
Inactive CompaniesN/A
Active IndicationsHemophilia AMuscular Dystrophy, DuchenneHerpesviridae Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A